D. Nelson

Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells.

L. Old, W. Mercer, A. Deleo, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Comparison of a recombinant endotoxin-neutralizing protein with a human monoclonal antibody to endotoxin for the treatment of Escherichia coli sepsis in rats.

N. Kuppermann, R. Saladino, C. Thompson, 1994, The Journal of infectious diseases.

Influence of subinhibitory levels of antibiotics on expression of Escherichia coli lipopolysaccharide and binding of anti-lipopolysaccharide monoclonal antibodies.

D. Nelson, I. Poxton, T. Delahooke, 1993, Journal of medical microbiology.

The B-Subunit of Cholera Toxin Induces Immunoregulatory Cells and Prevents Diabetes in the NOD Mouse

D. Sobel, A. Mazumder, D. Nelson, 1998, Diabetes.

Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats.

N. Kuppermann, B. Hammer, C. Thompson, 1995, Critical care medicine.

Monoclonal antibodies as probes for detecting lipopolysaccharide expression on Escherichia coli from different growth conditions.

D. Nelson, I. Poxton, A. Bathgate, 1991, Journal of general microbiology.

Inhibition of SV40-induced cellular DNA synthesis by microinjection of monoclonal antibodies.

W. Mercer, R. Baserga, D. Nelson, 1983, Virology.

A comparison of immunoblotting, flow cytometry and ELISA to monitor the binding of anti-lipopolysaccharide monoclonal antibodies.

W. Neill, D. Nelson, I. Poxton, 1990, Journal of immunological methods.

Monoclonal anti-dipeptide antibodies cross-react with detyrosinated and glutamylated forms of tubulins.

A. Frankfurter, M. Kimble, R. Kuriyama, 1995, Cell motility and the cytoskeleton.